PAXMEDICA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.37 USD | -46.24% |
|
-47.46% | -51.12% |
Valuation
| Fiscal Period: December | 2023 | 2024 |
|---|---|---|
| Capitalization 1 | 3.429 | 2.762 |
| Enterprise Value (EV) 1 | 3.429 | 2.762 |
| P/E ratio | -0.07 x | -0.34 x |
| Yield | - | - |
| Capitalization / Revenue | - | - |
| EV / Revenue | - | - |
| EV / EBITDA | - | - |
| EV / FCF | - | - |
| FCF Yield | - | - |
| Price to Book | - | - |
| Nbr of stocks (in thousands) | 4,530 | 7,466 |
| Reference price 2 | 0.7570 | 0.3700 |
| Announcement Date | 24-03-11 | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2023 | 2024 |
|---|---|---|
| Net sales 1 | - | - |
| EBITDA | - | - |
| EBIT 1 | -16.15 | -12.2 |
| Operating Margin | - | - |
| Earnings before Tax (EBT) 1 | -18.29 | -12.2 |
| Net income 1 | -18.29 | -12.2 |
| Net margin | - | - |
| EPS 2 | -11.00 | -1.080 |
| Free Cash Flow | - | - |
| FCF margin | - | - |
| FCF Conversion (EBITDA) | - | - |
| FCF Conversion (Net income) | - | - |
| Dividend per Share | - | - |
| Announcement Date | 24-03-11 | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|
| Net sales | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| EBIT | -4.386 | - | - | - | - |
| Operating Margin | - | - | - | - | - |
| Earnings before Tax (EBT) | -5.92 | - | - | - | - |
| Net income | -5.92 | - | - | - | - |
| Net margin | - | - | - | - | - |
| EPS 1 | - | -0.4300 | -0.3000 | -0.2200 | -0.2100 |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 24-03-11 | - | - | - | - |
1USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2023 | 2024 |
|---|---|---|
| Net Debt | - | - |
| Net Cash position | - | - |
| Leverage (Debt/EBITDA) | - | - |
| Free Cash Flow | - | - |
| ROE (net income / shareholders' equity) | - | - |
| ROA (Net income/ Total Assets) | - | - |
| Assets 1 | - | - |
| Book Value Per Share | - | - |
| Cash Flow per Share | - | - |
| Capex | - | - |
| Capex / Sales | - | - |
| Announcement Date | 24-03-11 | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.37
USD
Average target price
3
USD
Spread / Average Target
+710.81%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -51.12% | 2.76M | |
| +26.28% | 48.09B | |
| -3.99% | 40.43B | |
| +45.32% | 40.62B | |
| -6.20% | 28.36B | |
| +6.36% | 24.89B | |
| -21.47% | 19.01B | |
| +27.58% | 12.09B | |
| -2.75% | 11.8B | |
| -2.02% | 11.88B |
- Stock Market
- Equities
- PXMD Stock
- Financials PaxMedica, Inc.
